Key facts
- Notable investors include Crush It Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Leniva by Dr. Amin Javid
- ·The full record, as it builds
Funding rounds
No funding rounds for Leniva by Dr. Amin Javid are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Leniva by Dr. Amin Javid
Provider of a physician-formulated botanical pain balm intended for targeted relief of muscle aches, joint discomfort, and post-exercise recovery. The company offers doctor-formulated balm that harnesses powerful, time-honored botanical extracts, combining clinically proven menthol and camphor with a synergy of rare botanicals, enabling clients to achieve drug-free relief.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Beverly Hills, CA, United States
- Founded
- 2023
- Website
- leniva.com/
- Ownership
- Privately Held (backing)
Leniva by Dr. Amin Javid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Leniva by Dr. Amin Javid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Leniva by Dr. Amin Javid in its N-PORT filings yet. We sweep new filings monthly.